Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference
Intelligent Bio Solutions to Participate in the Noble Capital Markets' 20th Annual Emerging Growth Equity Conference
NEW YORK, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that its management team will present at the upcoming Noble Capital Markets' 20th Annual Emerging Growth Equity Conference on December 3-4, 2024, in Boca Raton, FL.
紐約,2024年11月21日(環球新聞社)--智能生物解決方案公司(納斯達克:INBS)("INBS"或"公司"),一家提供智能、快速、無創檢測解決方案的醫療科技公司,今天宣佈其管理團隊將於2024年12月3-4日在弗羅裏達博卡拉頓舉行的諾貝爾資本市場第20屆新興增長股權會議上發表演講。
Noble Capital Markets' 20th Annual Emerging Growth Equity Conference
Dates: December 3-4, 2024
Location: Florida Atlantic University, Boca Raton, FL
Presentation Day and Time: Wednesday, December 4, 2024, at 2:00 p.m. ET
Presentation Location: Presentation Room 3
諾貝爾資本市場第20屆新興增長股權會議
日期:2024年12月3-4日
地點:佛羅里達大西洋大學,博卡拉頓,FL
演講日期和時間:2024年12月4日,美國東部時間下午2:00
演講地點:演講廳3
A link to the recording of the presentation will be available on INBS's Investor Relations website two days after the event.
INBS投資者關係網站上將在活動結束後兩天提供演示錄像的鏈接。
Management will also be available during the event for one-on-one meetings with the investment community. To schedule a meeting, please contact your NobleCon representative or KCSA Strategic Communications by emailing INBS@kcsa.com.
管理層還將在活動期間與投資社區進行一對一會議。要安排會議,請通過電子郵件聯繫您的NobleCon代表或KCSA戰略通信的INBS代表。
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company delivering innovative, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company's current customer segments outside the US include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.
關於智能生物解決方案股份有限公司:智能生物解決方案股份有限公司(納斯達克:INBS)是一家提供創新、快速、無創檢測解決方案的醫療技術公司。該公司認爲其智能指紋毒品篩查系統將通過指紋汗液分析,革新便攜式測試,具有更廣泛的應用前景。作爲一種衛生和經濟高效的系統,該測試可對在職場常見的藥物使用(包括阿片類、可卡因、甲基苯丙胺和大麻)進行篩查。該技術在數秒內完成採樣並在不到十分鐘內得出結果,對於安全關鍵行業的僱主來說,這將是一種寶貴的工具。另外,該公司的生物傳感器平台有潛力檢測各種疾病症狀,包括傳染病到免疫性疾病。該公司目前的客戶群包括建築、製造和工程、運輸和物流公司、藥物治療機構和驗屍官。
納斯達克:Intelligent Bio Solutions Inc. (INBS)是一家醫療技術公司,提供創新、快速、非侵入性的測試解決方案。該公司認爲其Intelligent Fingerprinting毒品篩查系統將通過指紋汗液分析革新便攜式測試,這具有在其他領域中有更廣泛應用潛力。設計爲衛生和經濟實惠的系統,該測試旨在篩查最近在工作場所常見的藥物使用,包括阿片類藥物、可卡因、冰毒和大麻。採樣只需幾秒鐘,結果在不到十分鐘內出來,這項技術將成爲安全關鍵行業僱主的寶貴工具。該公司目前在美國以外的客戶群包括建築、製造和工程、運輸和物流公司、藥物治療機構和法醫。
For more information, visit:
請訪問:
Company Contact:
Intelligent Bio Solutions Inc.
info@ibs.inc
公司聯繫方式:
智能生物解決方案公司
info@ibs.inc
Investor & Media Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
PH: (212) 896-1254
INBS@kcsa.com
投資者及媒體聯繫方式:
Valter Pinto,董事總經理
KCSA戰略傳播
PH:(212) 896-1254
INBS@kcsa.com
譯文內容由第三人軟體翻譯。